 |
JOURNAL TOOLS |
| Opzioni di pubblicazione |
| eTOC |
| Per abbonarsi |
| Sottometti un articolo |
| Segnala alla tua biblioteca |
ARTICLE TOOLS |
| Publication history |
| Estratti |
| Permessi |
| Per citare questo articolo |
| Share |
I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
REVIEW SUBCLINICAL ENDOCRINE DISEASE: OLD AND NEW CLINICAL SCENARIOS
Minerva Endocrinology 2021 September;46(3):238-42
DOI: 10.23736/S2724-6507.20.03176-4
Copyright © 2020 EDIZIONI MINERVA MEDICA
lingua: Inglese
Subclinical hypothyroidism
Jessica CHBAT 1, Shereen EZZAT 1, Giampaolo PAPI 2 ✉
1 Endocrine Oncology Site Group, Princess Margaret Cancer Center, Toronto, Canada; 2 Unit of Endocrinology, Northern Area, USL Modena, Modena, Italy
Subclinical hypothyroidism (i.e. a condition characterized by serum TSH concentrations above the normal reference range in the presence of normal serum T4 levels) affects 4 to 20% of the population living in iodine-sufficient areas. The present work reviewed the clinical challenges regarding the signs and symptoms possibly related to subclinical hypothyroidism and the most recent guideline recommendations to treatment.
KEY WORDS: Hypothyroidism; Thyroid diseases; Diagnosis; Therapeutics